Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of P-4 (propiverine) in Overactive Bladder
jRCT2080220467Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in overactive bladder (OAB) comparing P-4 (propiverine) with Placebo (2 arms).
02
Drugs
propiverine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2080220467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220467.